The transfer of vaccine technology to developing countries: the Latin American experienceHOMMA, A; KNOUSS, R. F.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 47-54, issn 0266-4623Conference Paper

Desirable immunologic characteristics for the development of an ideal vaccineADA, G.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 71-80, issn 0266-4623Conference Paper

The contribution of immunization to economic developmentPARKER, D; HILL, T.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 21-29, issn 0266-4623Conference Paper

The role of vaccine research and development in the scientific development of middle-income countriesMARTINEZ-PALOMO, A; LOPEZ-CERVANTES, M; FREEMAN, P et al.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 30-38, issn 0266-4623Conference Paper

Effective mucosal immunity: current concepts for vaccine delivery and immune response analysisMCGHEE, J. R; KIYONO, H.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 93-106, issn 0266-4623Conference Paper

Immunization of the neonateLAWTON, A. R.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 154-160, issn 0266-4623Conference Paper

Conference on vaccines and public healthFREEMAN, Phyllis; RABINOVICH, Regina; ROBBINS, Anthony et al.International journal of technology assessment in health care. 1994, Vol 10, Num 1, issn 0266-4623, 198 p.Conference Proceedings

Live attenuated vaccine vectorsMEKALANOS, J. J.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 131-142, issn 0266-4623Conference Paper

Novel approaches to controlled-release antigen deliveryCOHEN, S; ALONSO, M. J; LANGER, R et al.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 121-130, issn 0266-4623Conference Paper

Synthetic peptides and purified antigens as vaccinesBROWN, F.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 161-166, issn 0266-4623Conference Paper

The global capacity for manufacturing vaccines: prospects for competition and collaboration among producers in the next decadeROBBINS, A; ARITA, I.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 39-46, issn 0266-4623Conference Paper

Adjuvants and immune enhancementALLISON, A. C.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 107-120, issn 0266-4623Conference Paper

Maternal immunization to prevent infectious diseases in the neonate or infantINSEL, R. A; AMSTEY, M; WOODIN, K et al.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 143-153, issn 0266-4623Conference Paper

Modern concepts in immune recognition and lymphocyte activation: relevance for the development of useful vaccinesGERMAIN, R. N.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 81-92, issn 0266-4623Conference Paper

The thermostability of vaccines: technologies for improving the thermostability of the oral poliovirus vaccineLEMON, S. M; MILSTIEN, J. B.International journal of technology assessment in health care. 1994, Vol 10, Num 1, pp 177-184, issn 0266-4623Conference Paper